Insider · CIK 0001539937

Khattar Jack A.

Reports to the SEC for 4 companies · ROCKVILLE, MD

sec.gov

Transactions

Companies

Filings

CIK

0001539937

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-08-12	SUPNSUPERNUS PHARMACEUTICALS, INC.M Exercise/Conversion	Director, President, CEO	MExercise/Conversion	+29.8K sh	—	—	1,270,993
2026-08-12	SUPNSUPERNUS PHARMACEUTICALS, INC.F Tax Payment	Director, President, CEO	FTax Payment	−12.6K sh	$46.57	−$589K	1,258,351
2026-08-12	SUPNSUPERNUS PHARMACEUTICALS, INC. · Performance Share UnitM Exercise/Conversion	Director, President, CEO	MExercise/Conversion	−29.8K sh	—	—	0
2026-07-29	SUPNSUPERNUS PHARMACEUTICALS, INC. · Performance Share UnitA Award	Director, President, CEO	AAward	+29.8K sh	—	—	29,849
2026-06-17	CGTXCOGNITION THERAPEUTICS INCA Award	Director	AAward	+25K sh	—	—	73,500
2026-03-13	SUPNSUPERNUS PHARMACEUTICALS, INC.J Other	Director, President, CEO	JOther	+12.5K sh	—	—	1,241,144
2026-03-13	SUPNSUPERNUS PHARMACEUTICALS, INC.J Other	Director, President, CEO	JOther	−12.5K sh	—	—	993,100
2026-03-13	SUPNSUPERNUS PHARMACEUTICALS, INC.S Sale	Director, President, CEO	SSale	−24.1K sh	$50.09	−$1.21M	968,962
2026-03-13	SUPNSUPERNUS PHARMACEUTICALS, INC.S Sale	Director, President, CEO	SSale	−10.7K sh	$51.00	−$548K	958,220
2026-03-13	SUPNSUPERNUS PHARMACEUTICALS, INC.S Sale	Director, President, CEO	SSale	−120 sh	$51.75	−$6,210	958,100
2026-03-06	SUPNSUPERNUS PHARMACEUTICALS, INC.M Exercise/Conversion	Director, President, CEO	MExercise/Conversion	+38.6K sh	—	—	1,245,218
2026-03-06	SUPNSUPERNUS PHARMACEUTICALS, INC.F Tax Payment	Director, President, CEO	FTax Payment	−16.6K sh	$54.73	−$907K	1,228,644
2026-03-06	SUPNSUPERNUS PHARMACEUTICALS, INC. · Performance Share UnitM Exercise/Conversion	Director, President, CEO	MExercise/Conversion	−38.6K sh	—	—	0
2026-02-28	SUPNSUPERNUS PHARMACEUTICALS, INC. · Performance Share UnitA Award	Director, President, CEO	AAward	+38.6K sh	—	—	38,640
2026-02-18	SUPNSUPERNUS PHARMACEUTICALS, INC. · Employee Stock Option (Right to Buy)A Award	Director, President, CEO	AAward	+342K sh	—	—	341,610
2025-10-09	SUPNSUPERNUS PHARMACEUTICALS, INC.M Exercise/Conversion	Director, President, CEO	MExercise/Conversion	+81.3K sh	$25.30	+$2.06M	1,266,478
2025-10-09	SUPNSUPERNUS PHARMACEUTICALS, INC.S Sale	Director, President, CEO	SSale	−58.4K sh	$50.55	−$2.95M	1,208,107
2025-10-09	SUPNSUPERNUS PHARMACEUTICALS, INC.S Sale	Director, President, CEO	SSale	−1,529 sh	$51.46	−$78.7K	1,206,578
2025-10-09	SUPNSUPERNUS PHARMACEUTICALS, INC. · Employee Stock Option (Right to Buy)M Exercise/Conversion	Director, President, CEO	MExercise/Conversion	−81.3K sh	—	—	0
2025-10-07	SCPHscPharmaceuticals Inc.U Disposition from Tender	Director	UDisposition from Tender	−5,000 sh	—	—	0
2025-10-07	SCPHscPharmaceuticals Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−30K sh	—	—	0
2025-10-07	SCPHscPharmaceuticals Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−19.8K sh	—	—	0
2025-10-07	SCPHscPharmaceuticals Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−16.3K sh	—	—	0
2025-10-07	SCPHscPharmaceuticals Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−6,124 sh	—	—	0
2025-10-02	SUPNSUPERNUS PHARMACEUTICALS, INC.M Exercise/Conversion	Director, President, CEO	MExercise/Conversion	+2,267 sh	$25.30	+$57.4K	1,163,137
2025-10-02	SUPNSUPERNUS PHARMACEUTICALS, INC.S Sale	Director, President, CEO	SSale	−1,904 sh	$48.06	−$91.5K	1,161,233
2025-10-02	SUPNSUPERNUS PHARMACEUTICALS, INC. · Employee Stock Option (Right to Buy)M Exercise/Conversion	Director, President, CEO	MExercise/Conversion	−2,267 sh	—	—	81,250
2025-10-02	SUPNSUPERNUS PHARMACEUTICALS, INC.M Exercise/Conversion	Director, President, CEO	MExercise/Conversion	+20K sh	—	—	1,181,233
2025-10-02	SUPNSUPERNUS PHARMACEUTICALS, INC.F Tax Payment	Director, President, CEO	FTax Payment	−7,796 sh	$46.21	−$360K	1,173,437
2025-10-02	SUPNSUPERNUS PHARMACEUTICALS, INC.M Exercise/Conversion	Director, President, CEO	MExercise/Conversion	+19.3K sh	—	—	1,192,757
2025-10-02	SUPNSUPERNUS PHARMACEUTICALS, INC.F Tax Payment	Director, President, CEO	FTax Payment	−7,529 sh	$46.21	−$348K	1,185,228
2025-10-02	SUPNSUPERNUS PHARMACEUTICALS, INC. · Performance Share UnitM Exercise/Conversion	Director, President, CEO	MExercise/Conversion	−20K sh	—	—	0
2025-10-02	SUPNSUPERNUS PHARMACEUTICALS, INC. · Performance Share UnitsM Exercise/Conversion	Director, President, CEO	MExercise/Conversion	−19.3K sh	—	—	0
2025-10-01	SUPNSUPERNUS PHARMACEUTICALS, INC.M Exercise/Conversion	Director, President, CEO	MExercise/Conversion	+53.8K sh	$25.30	+$1.36M	1,201,043
2025-10-01	SUPNSUPERNUS PHARMACEUTICALS, INC.S Sale	Director, President, CEO	SSale	−40.2K sh	$48.07	−$1.93M	1,160,870
2025-10-01	SUPNSUPERNUS PHARMACEUTICALS, INC. · Employee Stock Option (Right to Buy)M Exercise/Conversion	Director, President, CEO	MExercise/Conversion	−53.8K sh	—	—	83,517
2025-09-30	SUPNSUPERNUS PHARMACEUTICALS, INC.M Exercise/Conversion	Director, President, CEO	MExercise/Conversion	+11.5K sh	$25.30	+$291K	1,155,846
2025-09-30	SUPNSUPERNUS PHARMACEUTICALS, INC.S Sale	Director, President, CEO	SSale	−8,588 sh	$48.25	−$414K	1,147,258
2025-09-30	SUPNSUPERNUS PHARMACEUTICALS, INC. · Employee Stock Option (Right to Buy)M Exercise/Conversion	Director, President, CEO	MExercise/Conversion	−11.5K sh	—	—	137,302
2025-09-29	SUPNSUPERNUS PHARMACEUTICALS, INC.M Exercise/Conversion	Director, President, CEO	MExercise/Conversion	+13.7K sh	$25.30	+$346K	1,154,571
2025-09-29	SUPNSUPERNUS PHARMACEUTICALS, INC.S Sale	Director, President, CEO	SSale	−10.2K sh	$48.02	−$491K	1,144,336
2025-09-29	SUPNSUPERNUS PHARMACEUTICALS, INC. · Employee Stock Option (Right to Buy)M Exercise/Conversion	Director, President, CEO	MExercise/Conversion	−13.7K sh	—	—	148,812
2025-09-23	SUPNSUPERNUS PHARMACEUTICALS, INC.M Exercise/Conversion	Director, President, CEO	MExercise/Conversion	+47.9K sh	$12.98	+$622K	1,170,396
2025-09-23	SUPNSUPERNUS PHARMACEUTICALS, INC.S Sale	Director, President, CEO	SSale	−29.5K sh	$47.23	−$1.39M	1,140,883
2025-09-23	SUPNSUPERNUS PHARMACEUTICALS, INC. · Employee Stock Option (Right to Buy)M Exercise/Conversion	Director, President, CEO	MExercise/Conversion	−47.9K sh	—	—	0
2025-09-22	SUPNSUPERNUS PHARMACEUTICALS, INC.M Exercise/Conversion	Director, President, CEO	MExercise/Conversion	+27.1K sh	$12.98	+$351K	1,139,043
2025-09-22	SUPNSUPERNUS PHARMACEUTICALS, INC.S Sale	Director, President, CEO	SSale	−16.6K sh	$47.02	−$780K	1,122,456
2025-09-22	SUPNSUPERNUS PHARMACEUTICALS, INC. · Employee Stock Option (Right to Buy)M Exercise/Conversion	Director, President, CEO	MExercise/Conversion	−27.1K sh	—	—	47,940
2025-09-10	SUPNSUPERNUS PHARMACEUTICALS, INC. · Performance Share UnitA Award	Director, President, CEO	AAward	+20K sh	—	—	20,000
2025-09-10	SUPNSUPERNUS PHARMACEUTICALS, INC. · Performance Share UnitsA Award	Director, President, CEO	AAward	+19.3K sh	—	—	19,320

Recent filings

Accepted (ET)
Aug 144
Khattar Jack A.0001539937-26-000012
SEC(opens sec.gov)
Jul 314
Khattar Jack A.0001539937-26-000010
SEC(opens sec.gov)
Jun 224
Khattar Jack A.0001104659-26-076477
SEC(opens sec.gov)
Mar 164
Khattar Jack A.0001539937-26-000008
SEC(opens sec.gov)
Mar 104
Khattar Jack A.0001539937-26-000006
SEC(opens sec.gov)
Mar 34
Khattar Jack A.0001539937-26-000004
SEC(opens sec.gov)
Feb 204
Khattar Jack A.0001539937-26-000002
SEC(opens sec.gov)
Oct 104
Khattar Jack A.0001628280-25-044830
SEC(opens sec.gov)
Oct 74
Khattar Jack A.0001193125-25-233528
SEC(opens sec.gov)

Companies

Address

C/O SUPERNUS PHARMACEUTICALS INC. 9715 KEY WEST AVENUE

ROCKVILLE, MD, 20850